We find that AT1-R blockade inhibited cellular proliferation and anchorage-independent growth of lung cancer cells, as quantified by BrdU incorporation (Fig. 8, A and B) and growth in soft agar (Fig. 8, C and D) assays, respectively. The gene discussed is AGTR1; the disease is lung carcinoma.